Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Breastcancer × Dehydroepiandrosterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Polycystic Ovary Syndrome 2 Vaginal Atrophy 1 Triple Negative Breast Neoplasms 1 Sexual Dysfunction, Physiological 1 Sarcoma, Synovial 1 Rectal Neoplasms 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Metastatic Breastcancer 1 Insulin Resistance 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Depression 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Atrophic Vaginitis 1 Anxiety Disorders 1 Anus Neoplasms 1

Interventions

Dehydroepiandrosterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02000375 2016-09-29

ARTT

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated

Metastatic Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡